SynGen Inc. enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. Our products provide an important enabling platform for use in diagnostic, research, and clinical processes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/19/12 | $5,000,000 | Series A |
Bay City Capital | undisclosed |
| 10/06/14 | undisclosed |
Bay City Capital | undisclosed |
